Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Regulatory demands are making VCs’ exit paths more expensive

Nov. 1, 2005

By Jennifer Boggs

Cytokinetics Gains Access To $75M Equity Financing Facility

Nov. 1, 2005

By Jennifer Boggs

Cytokinetics Gains Access To $75M Equity Financing Facility

Nov. 1, 2005

By Jennifer Boggs

Pharma Deals For Early Stage Drugs Can Be Blessing, Curse

Oct. 31, 2005

By Jennifer Boggs

Surface Logix Raising $42M Through Series D Financing

Oct. 31, 2005

By Jennifer Boggs

Pharma Deals For Early Stage Drugs Can Be Blessing, Curse

Oct. 31, 2005

By Jennifer Boggs

Surface Logix Raising $42M Through Series D Financing

Oct. 31, 2005

By Jennifer Boggs

NicOx Licenses Respiratory Drug To Topigen For 54.9M

Oct. 28, 2005

By Jennifer Boggs

NicOx Licenses Respiratory Drug To Topigen For 54.9M

Oct. 28, 2005

By Jennifer Boggs

Infectious Disease Firm Idenix Raises $150M In Public Offering

Oct. 27, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...